apixaban - Robuta Search

https://adisinsight.springer.com/drugsafety/803861770?error=cookies_not_supported&code=d51233be-b980-4a71-9f8b-dd398a589f8d Apixaban/heparin/warfarin - AdisInsight A male patient [age at reaction onset not stated] developed drug-induced thrombocytopenia during treatment with heparin for thrombosis. Additionally, he apixaban heparin warfarin adisinsight https://digital.library.adelaide.edu.au/items/693f6b85-ea15-4547-878e-e70c40066b6e Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial... Background: Clinical situations occur where expedient assessment of the anticoagulant activity of the direct factor Xa (FXa) inhibitors is required. Although... of the comparison effects apixaban https://pubmed.ncbi.nlm.nih.gov/34343673/ Acute generalized exanthematous pustulosis to a novel oral anticoagulant (apixaban) Acute generalized exanthematous pustulosis to a novel oral anticoagulant (apixaban) a novel acute generalized oral anticoagulant https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=095a08ac-cf0e-497e-a682-ddef38d6b29c DailyMed - APIXABAN tablet, film coated dailymed apixaban tablet film coated https://about.ebsco.com/clinical-decisions/dynamed-solutions/about/ebm-focus/apixaban-reduces-stroke-risk-without Apixaban Reduces Stroke Risk without Increasing Bleeding Compared to Aspirin in Patients with... https://pubmed.ncbi.nlm.nih.gov/41904964/ Extended Low-Dose Apixaban and Superficial Vein Thrombosis: Post Hoc Analysis of the HI-PRO... Extended Low-Dose Apixaban and Superficial Vein Thrombosis: Post Hoc Analysis of the HI-PRO Randomized Clinical Trial https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bristol-myers-squibb-voluntarily-recalls-one-lot-eliquis-apixaban-5-mg-tablets Bristol-Myers Squibb Voluntarily Recalls One Lot of Eliquis (apixaban) 5 mg Tablets | FDA Bristol-Myers Squibb Company (NYSE: BMY) is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed... bristol myers squibb https://pubmed.ncbi.nlm.nih.gov/41812192/ Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism Among patients with acute venous thromboembolism, the risk of clinically relevant bleeding was significantly lower with apixaban than with rivaroxaban during... bleeding risk apixaban vs rivaroxaban https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=19a60552-374d-4b8b-a8ce-ceae252ea5ba&type=display These highlights do not include all the information needed to use APIXABAN TABLETS safely and... https://scholars.uky.edu/en/projects/a-phase-iii-randomized-open-label-multi-center-study-of-the-safet/fingerprints/ A Phase III Randomized, Open label, Multi-Center Study of the Safety and Efficacy of Apixaban for... https://adisinsight.springer.com/trials/700307053?error=cookies_not_supported&code=3c1204aa-4089-48b6-8232-a17ccca9a2e1 A study to evaluate the safety and efficacy of Novel oral anticoagulation (Apixaban or rivaroxaban)... This study evaluated the safety and efficacy of Novel oral anticoagulation (Apixaban or rivaroxaban) in patients with CF-LVADs after failed warfarin therapy. https://adisinsight.springer.com/drugsafety/803320483?error=cookies_not_supported&code=bbb34724-8e45-4320-b25a-cceb178f6612 Apixaban - AdisInsight In a retrospective study, one patient [age and sex not stated] was described, who developed bleeding event following treatment with apixaban anticoagulation apixaban adisinsight https://scholars.duke.edu/publication/1568121 Scholars@Duke publication: Reduced dose, but not reduced risk: rates of inappropriate apixaban dose... https://scholars.uky.edu/es/projects/a-phase-iii-randomized-open-label-multi-center-study-of-the-safet/ A Phase III Randomized, Open label, Multi-Center Study of the Safety and Efficacy of Apixaban for... https://adisinsight.springer.com/drugsafety/803744206?error=cookies_not_supported&code=f8b6839e-cf15-483a-a998-b2dfff77ae41 Apixaban - AdisInsight An 88-year-old woman developed spontaneous oesophageal haematoma during treatment with apixaban for atrial fibrillation [route, dosage and duration of treatment apixaban adisinsight https://ce.massmed.nejm.org/nejm-weekly-cme/content/bleeding-risk-apixaban-vs-rivaroxaban-acute-venous-thromboembolism Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism | MMS/NEJM Continuing... https://adisinsight.springer.com/drugsafety/803927204?error=cookies_not_supported&code=c6a5cd25-865b-46c1-b683-6727274d31e0 Rivaroxaban/Apixaban - AdisInsight Fifty-one children with malignancy-associated venous thromboembolism or receiving thromboprophylaxis (53% female; median age 14.4 years) were managed with rivaroxaban apixaban adisinsight https://portal.fis.tum.de/en/publications/effect-of-the-fxa-inhibitors-rivaroxaban-and-apixaban-on-platelet/ Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with... https://adisinsight.springer.com/trials/700391667?error=cookies_not_supported&code=b5260615-c0d4-41ff-8a44-7de27e298190 Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After... The purpose of this study is to determine whether Apixaban is effective and safe in the treatment of portal vein thrombosis Occurring more than one year after https://adisinsight.springer.com/drugsafety/803928818?error=cookies_not_supported&code=fe5b4842-a36e-40b9-b8a6-189575e92f89 Apixaban/Rivaroxaban - AdisInsight One hundred and forty patients [age and sex not stated] with venous thromboembolism treated in a trial of apixaban versus rivaroxaban experienced clinically apixaban rivaroxaban adisinsight https://ctgate.cci.fsu.edu/representativeness-of-the-dabigatran-apixaban-and-rivaroxaban-clinical-trial-populations-to-real-world-atrial-fibrillation-patients-in-the-united-kingdom-a-cross-sectional-analysis-using-the-general/ Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to... Title : Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United... of the clinical trial representativeness dabigatran apixaban https://research.utwente.nl/en/publications/apixaban-versus-no-anticoagulation-after-anticoagulation-associat/ Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in... apixaban versus anticoagulation associated haemorrhage https://experts.mcmaster.ca/scholarly-works/2168740 Can a Single Measurement of Apixaban Levels... Learn about the scholarly work entitled Can a Single Measurement of Apixaban Levels... single measurement apixaban levels https://pubmed.ncbi.nlm.nih.gov/19470889/ Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy... We observed a dose-related increase in bleeding and a trend toward a reduction in ischemic events with the addition of apixaban to antiplatelet therapy in... https://adisinsight.springer.com/drugsafety/803797175?error=cookies_not_supported&code=6b6fc383-770a-4997-baaf-b2c39bd14cc2 Apixaban - AdisInsight An approximately 47-year old woman misused apixaban therapy for deep vein thrombosis [route and dosage not stated].The woman had a medical history of type-2 apixaban adisinsight https://consultqd.clevelandclinic.org/proact-xa-apixaban-is-not-a-safe-warfarin-substitute-with-mechanical-aortic-valve PROACT Xa: Apixaban Is Not a Safe Warfarin Substitute With Mechanical Aortic Valve The factor Xa inhibitor failed to demonstrate noninferiority to warfarin in preventing valve thrombosis or thromboembolism in conjunction with the bileaflet... https://adisinsight.springer.com/drugsafety/803873768?error=cookies_not_supported&code=f0442bf0-632e-4f87-922c-9b935fa0951e Apixaban - AdisInsight A 25-year-old man exhibited lack of efficacy during treatment with apixaban for pulmonary embolism [dosage and route not stated].*The man presented to hospital apixaban adisinsight https://pubmed.ncbi.nlm.nih.gov/?term=apixaban&filter=pubt.meta-analysis&filter=pubt.randomizedcontrolledtrial apixaban - Search Results - PubMed apixaban - Search Results - PubMed search results apixaban pubmed https://adisinsight.springer.com/drugsafety/803909192?error=cookies_not_supported&code=1a902b9c-0374-4be7-b433-997f525cb73f Apixaban/Rivaroxaban/Warfarin - AdisInsight In a retrospective study involving 398 patients, who had recorded venous thromboembolism between 1 January 2012 and 31 December 2021, 9 patients (7 men and 2 apixaban rivaroxaban warfarin adisinsight https://adisinsight.springer.com/patents/800023201 Apixaban - Bristol-Myers Squibb/Pfizer - AdisInsight bristol myers squibb apixaban pfizer adisinsight https://hsrc.himmelfarb.gwu.edu/gwhpubs/7755/ "Two-year outcomes in the direct oral anticoagulant apixaban in left ve" by Aditya Mehta, Pramita... Anticoagulation with apixaban was previously demonstrated to be feasible without excess hemocompatibility-related adverse events (HRAEs) at 6 months but...